Biomaterials at the Heart of Regeneration Ingenious scaffolds, gels, and matrices are giving cardiac regenerative medicine a boost. Here, three pioneering researchers share how they are taking inspiration from nature, improving delivery, and speeding translation of novel engineered materials – from injection-molded heart valves to cell-delivery patches – for cardiac care. Matteo Santin, Stefan Jockenhövel, and Garry Duffy | 11/23/2016











Are we ready for the regenerative medicine revolution? With Matteo Santin Regenerative medicine has the aim of “regenerating” damaged tissues rather than “replacing” them with implanted medical devices. This revolutionary approach is particularly relevant in developing new therapies to treat heart pathologies, and is a big focus for the field of cardiac biomaterials. Indeed, as President of the European Society for Biomaterials (ESB), I’ve launched a survey amongst the biomaterials community in Europe, and the preliminary data seem to show that a majority of our researchers are now focusing on developing new biomaterials for regenerative medicine, rather than for medical devices.

Read the full article now Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be! Login Email Password Forgot your password? Keep me logged in Log in Or register now - it’s free and always will be! You will benefit from: Unlimited access to ALL articles

News, interviews & opinions from leading industry experts Register Or Login via Social Media Twitter By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Matteo Santin, Stefan Jockenhövel, and Garry Duffy

Matteo Santin is the President of the European Society for Biomaterials



Stefan Jockenhövel is the Director of the Department of Biohybrid & Medical Textiles at RWTH Aachen University



Garry Duffy is a researcher at the Royal College of Surgeons in Ireland.